The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study

EuroIntervention 2010;6:195-205.

1.Erasmus Medisch Centrum, Rotterdam, The Netherlands; 2. Instituto Dante Pazzanese, Sao Paulo, Brazil; 3. Mercy Angiography Unit, Auckland, New Zealand; 4. University Hospital Bern, Bern, Switzerland; 5. Academisch Ziekenhuis Middelheim, Antwerpen, Belgi

Aims: Novolimus, a macrocyclic lactone with anti-proliferative properties, has a similar efficacy to currently available agents; however it requires a lower dose, and less polymer, and is t

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

The impact of bivalirudin on percutaneous coronary intervention-related bleeding